Founded in 2012, MindMaze is a global leader in brain technology with a mission to accelerate humanity's ability to recover, learn and adapt. With over a decade of work at the intersection of neuroscience, biosensing, engineering, mixed reality, and artificial intelligence, we have enhanced the recovery potential of patients with neurological diseases.

Combining FDA cleared and CE marked digital therapeutics with best-in-class motion analytics, AI, and cloud technologies, MindMaze aims to create the universal platform for brain health.

MindMaze Labs, the enterprising R&D division, extends the impact beyond healthcare by bringing groundbreaking neuroscience to everyday life, empowering the next generation of human-machine interfaces.

MindMaze has pioneered seminal research, received several awards and grants, launched innovative neurorehabilitation products, and achieved key certifications such as FDA 510(k) clearance and CE marks.

The company has expanded globally with operations in the US, UK, Germany, and Switzerland, and formed strategic partnerships with renowned medical institutions.

Besides healthcare, MindMaze collaborates with leading global brands through MindMaze Labs for applications in various industries including Formula 1 racing and technology development.